Listening...

Search Results

No Results

    See all results

    Sorry, I don't understand. Please try again
    1. EMEA Innovative Medicine /
    2. INCIVO® receives positive opinion from CHMP

    INCIVO® receives positive opinion from CHMP

    INCIVO® (Telaprevir) Receives European Commission Approval for Twice Daily Dosing for Treatment of Genotype-1 Chronic Hepatitis C Virus (HCV)